Increased blown-out myotomy risk observed in POEM-treated achalasia patients: Study
A recent study published in the American Journal of Gastroenterology raised concerns about the long-term effects of peroral endoscopic myotomy (POEM) in the treatment of achalasia. The study analyzed the prevalence, risk factors and associated symptoms of blown-out myotomy (BOM) among patients treated with POEM.
Achalasia affects the esophagus and makes it difficult for food and liquid to pass into the stomach. POEM is a minimally invasive procedure to treat achalasia by cutting the muscles at the lower end of the esophagus. Despite being effective, POEM distends the distal esophagus which is known as BOM, where the esophageal diameter increases by more than 50% at its widest point in the distal esophagus.
The study meticulously analyzed data from a randomized controlled trials that compared POEM with pneumatic dilation (PD) for achalasia. A total of 74 patients were treated at the study center, with 55 patients had available follow-up data over five years. Of these, 32 patients (58%) were treated with POEM and 23 (42%) with PD.
The results expressed a significant increase in the incidence of BOM among the POEM patients. Initially, at three months post-treatment, 11.5% (4 out of 38) of POEM patients developed BOM. This rose to 21.1% by one year, 27.8% by two years and 31.3% by five years. Also, none of the patients treated with PD developed BOM during the study period.
The study also highlighted that patients who developed BOM had higher Eckardt scores implying severe achalasia symptoms. These patients had higher total scores and more pronounced regurgitation symptoms when compared to the patients who underwent POEM without developing BOM. Also, POEM patients with BOM reported significantly more reflux symptoms. 85% of these patients experienced reflux when compared to 46% of the patients without BOM. They also had a higher acid exposure time, with an average of 24.5% when compared to 6% in non-BOM patients.
Overall, the findings suggest that while POEM is effective in treating achalasia, it carries a substantial risk of developing BOM which in turn is associated with increased acid exposure, reflux symptoms, and regurgitation. This study highlights the need for further research and clinical studies to optimize patient outcomes and illuminate the importance of weighing the benefits and risks of POEM.
Source:
Kuipers, T., Ponds, F. A., Fockens, P., Bastiaansen, B. A. J., Pandolfino, J. E., & Bredenoord, A. J. (2024). Focal Distal Esophageal Dilation (Blown-Out Myotomy) After Achalasia Treatment: Prevalence and Associated Symptoms. In American Journal of Gastroenterology. Ovid Technologies (Wolters Kluwer Health). https://doi.org/10.14309/ajg.0000000000002816
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.